Market Overview

Oppenheimer Initiates Coverage on Quest Diagnostics Incorporated at Underperform, Announces $53.00 undefined

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for DGX

DateFirmActionFromTo
Jan 2015Raymond JamesUpgradesUnderperformMarket Perform
Dec 2014Bank of AmericaMaintainsNeutral
Nov 2014Deutsche BankUpgradesHoldBuy

View More Analyst Ratings for DGX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (DGX)

Around the Web, We're Loving...

Get Benzinga's Newsletters